piperacillin and tazobactam
- Product NDC
- 67457-523
- 11-digit product format
- 674570523
- Labeler code
- 67457
- Product ID
- 67457-523_3921ae66-d2c1-413f-b848-47fa2ef20d14
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- piperacillin and tazobactam
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA065458
- Marketing category
- ANDA
- Marketing start
- 2016-06-30
- Marketing end
- 2021-07-31
- Substance
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Active strength
- 4 g/20mL; g/20mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC],Penicillins [CS],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 67457-523 | D | Discontinued by firm | 2026-08-10 | ||
| excluded package | package | 67457-523 | 67457-523-45 | D | Discontinued by firm | 2026-08-10 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 67457-523-45 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 67457-523-45 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 67457-523-45 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 67457-523-45 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 67457-523-45 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 67457-523-45 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 67457-523-45 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 67457-523-45 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 67457-523-45 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 67457-523-45 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 67457-523-45 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 67457-523-45 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065458-001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | |
| A065458-002 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | |
| A065458-003 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065458-001 | AP |
| A065458-002 | AP |
| A065458-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065458-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065458-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A065458-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-08-15 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065458-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065458-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065458-003 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065458-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065458-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065458-003 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065458-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065458-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065458-003 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065458-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065458-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065458-003 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065458-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065458-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065458-003 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065458-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065458-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065458-003 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065458-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065458-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065458-003 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065458-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065458-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065458-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065458-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065458-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065458-003 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065458-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065458-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065458-003 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065458-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065458-002 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065458-003 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065458-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065458-002 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065458-003 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065458-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065458-002 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065458-003 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065458-001 | AP | 1 | 8072bd15b7f6… |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67457-523-00 | EA - Each | 67457-523 | 54c1cec0-ba52-4eb5-8ff5-a6fd927eb99d | 1 | 2016-07-19 |
| 67457-523-45 | EA - Each | 67457-523 | d8066c88-ce7a-4834-be2e-973814763e05 | 1 | 2016-07-19 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PIPERACILLIN SODIUM | ACTIVE INGREDIENT | M98T69Q7HP | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, FOR SOLUTION [MYLAN INSTITUTIONAL LLC] | 2 | |
| TAZOBACTAM SODIUM | ACTIVE INGREDIENT | UXA545ABTT | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, FOR SOLUTION [MYLAN INSTITUTIONAL LLC] | 2 | |
| PIPERACILLIN ANHYDROUS | ACTIVE MOIETY | 9I628532GX | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, FOR SOLUTION [MYLAN INSTITUTIONAL LLC] | 2 | |
| TAZOBACTAM | ACTIVE MOIETY | SE10G96M8W | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, FOR SOLUTION [MYLAN INSTITUTIONAL LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Civica, Inc. | 7aebc0e6-89db-4ef0-b5ab-d6b3199bcfc4 | 2025-09-08 | Warnings, Adverse reactions | 065458 ANDA065458 |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | ONESOURCE SPECIALTY PHARMA LIMITED | 28258745-12e4-4f0f-b318-4a1a1bebc928 | 2025-07-21 | Warnings, Adverse reactions | 065458 ANDA065458 |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Armas Pharmaceuticals Inc. | 24d9b4f1-109c-4db4-8a99-03afff045b47 | 2024-09-27 | Warnings, Adverse reactions | 065458 ANDA065458 |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Armas Pharmaceuticals Inc. | bbd1e6ae-e19a-4572-a0ec-e78c8aa31d2a | 2024-09-27 | Warnings, Adverse reactions | 065458 ANDA065458 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 67457-523-45 | 67457052345 | 10 VIAL, SINGLE-USE in 1 CARTON (67457-523-45) > 20 mL in 1 VIAL, SINGLE-USE (67457-523-00) | 2016-06-30 | 2021-07-31 | No | No | Current |